Microanalysis in Pharmaceutical Product Development and Trouble-Shooting

Importance of Microanalysis in Pharmaceutical Development and Quality Control

The accurate identification of small particles and inclusions in pharmaceutical products is essential to ensure product safety and efficacy. While mid and near infrared spectroscopy can confirm overall composition, microscopic contaminants require spatially resolved analysis to trace contamination sources and support development and troubleshooting.

Study Objectives and Overview

This application note presents the use of the FTIR microscope LUMOS II for addressing contamination and compositional mapping in pharmaceutical tablets and liquid formulations. It aims to demonstrate rapid identification of inclusions, particle analysis, and chemical imaging of active pharmaceutical ingredients and excipients.

Methodology and Instrumentation

The core system is the compact LUMOS II FTIR microscope with full automation and intuitive software. Analysis was carried out in attenuated total reflectance mode without sample preparation. Key elements include

• LUMOS II FTIR microscope
• OPUS spectroscopic software with OPUS SEARCH and OPUS 3D modules
• ATR COMPLETE spectral library containing over 26000 reference spectra

Main Results and Discussion

• A yellow inclusion in a tablet was automatically mapped over a 10 by 10 micron area, leading to rapid identification as magnesium stearate via library search.
• Particles isolated from a sterile liquid formulation on a gold filter were identified as poly tetrafluoroethylene, differentiating them from formulation precipitates.
• ATR mapping of an ibuprofen tablet cross section over 500 by 325 microns with 25 micron resolution revealed distribution patterns of the API and excipients lactose, microcrystalline cellulose, and sodium dodecyl sulfate using linear combination analysis.

Practical Benefits and Applications

Spatially resolved FTIR microscopy accelerates troubleshooting in quality control by pinpointing contamination sources. Chemical imaging supports formulation development by visualizing component distribution and homogeneity, guiding optimization of tablet coatings and release profiles.

Future Trends and Potential Applications

Advances in software automation and library expansion will further reduce analysis time. Integration with artificial intelligence for spectral interpretation and development of higher spatial resolution optics will extend applications to nanoscale features and complex multilayer packaging materials.

Conclusion

FTIR microscopy using the LUMOS II platform provides a powerful tool for pharmaceutical microanalysis, combining ease of use with high spatial resolution and automated workflows. It enables both rapid contaminant identification and detailed compositional mapping to support quality control and product development.

Reference

• Bruker Optics application note AN M119 Microanalysis in Pharmaceutical Product Development and Trouble Shooting 2021